Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease

References

• RabeKFWatzHChronic obstructive pulmonary diseaseLancet2017389100821931194028513453
   PubMed Web of Science ®Google Scholar
• ZhouXLiQExacerbation of chronic obstructive pulmonary diseaseCell Biochem Biophys201573234935527352322
   PubMed Web of Science ®Google Scholar
• DürrUHSudheendraUSRamamoorthyALL-37, the only human member of the cathelicidin family of antimicrobial peptidesBiochim Biophys Acta2006175891408142516716248
   PubMed Web of Science ®Google Scholar
• VandammeDLanduytBLuytenWSchoofsLA comprehensive summary of LL-37, the factotum human cathelicidin peptideCell Immunol20122801223523246832
   PubMed Web of Science ®Google Scholar
• KahlenbergJMKaplanMJLittle peptide, big effects: the role of LL-37 in inflammation and autoimmune diseaseJ Immunol2013191104895490124185823
   PubMed Web of Science ®Google Scholar
• ZhangYJiangYSunCThe human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary diseaseBiochem Biophys Res Commun2014443110310924291709
   PubMed Web of Science ®Google Scholar
• YangYMGuoYFZhangHSSunTYAntimicrobial peptide LL-37 circulating levels in chronic obstructive pulmonary disease patients with high risk of frequent exacerbationsJ Thorac Dis20157474074525973241
   PubMed Web of Science ®Google Scholar
• PerssonLJAanerudMHardieJAAntimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary diseaseEur Respir J2017493160132828298400
   PubMed Web of Science ®Google Scholar
• SchuligaMNF-kappaB signaling in chronic inflammatory airway diseaseBiomolecules2015531266128326131974
   PubMed Web of Science ®Google Scholar
• Di StefanoACaramoriGOatesTIncreased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPDEur Respir J200220355656312358328
   PubMed Web of Science ®Google Scholar
• CaramoriGRomagnoliMCasolariPNuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbationsThorax200358434835112668802
   PubMed Web of Science ®Google Scholar
• PistolicJCosseauCLiYHost defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathwayJ Innate Immun20091325426720375583
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease“Could it be COPD?” Questionnaire Global initiative for chronic obstructive lung Disease (Gold), global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, global initiative for chronic obstructive lung Disease (Gold)2014 Available from: http://www.goldcopd.org/could-it-be-copd.htmlAccessed April 01, 2016
   Google Scholar
• BalsRHiemstraPSAntimicrobial peptides in COPD – basic biology and therapeutic applicationsCurr Drug Targets20067674375016787176
   PubMed Web of Science ®Google Scholar
• GombartAFBhanIBorregaardNLow plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysisClin Infect Dis200948441842419133797
   PubMed Web of Science ®Google Scholar
• QuraishiSADe PascaleGNeedlemanJSEffect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trialCrit Care Med20154391928193726086941
   PubMed Web of Science ®Google Scholar
• YeYCarlssonGKarlsson-SjöbergJMThe antimicrobial pro-peptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective studySci Rep201551168526119962
   PubMed Web of Science ®Google Scholar
• PavlovSIIvanovaIIGerovaDIChervenkovTGBalevSPSerum level of the human antimicrobial cathelicidin (hCAP18/LL-37) in patients with psoriasis vulgarisScripta Scientifica Medica20164823742
   Google Scholar
• AshenafiSMazurekJRehnAVitamin D3 status and the association with human cathelicidin expression in patients with different clinical forms of active tuberculosisNutrients2018106721
   Web of Science ®Google Scholar
• JiangYXiaoWZhangYXingYUrokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary diseaseRespirology201015693994620624254
   PubMed Web of Science ®Google Scholar
• ParameswaranGISethiSMurphyTFEffects of bacterial infection on airway antimicrobial peptides and proteins in COPDChest2011140361161721349930
   PubMed Web of Science ®Google Scholar
• GolecMReichelCLemieszekMCathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD patients and healthy individualsJ Biol Regul Homeost Agents201226461762523241112
   PubMed Web of Science ®Google Scholar
• SunCZhuMYangZLL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary diseaseLab Invest2014949991100224955895
   PubMed Web of Science ®Google Scholar
• GolecMReichelCMackiewiczBCathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPDAnn Agric Environ Med200916228929720047264
   PubMed Web of Science ®Google Scholar
• JiangYYXiaoWZhuMXThe effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary diseaseRespir Med2012106121680168922981321
   PubMed Web of Science ®Google Scholar
• MansbachJMHasegawaKAjamiNJSerum LL-37 levels associated with severity of bronchiolitis and viral etiologyClin Infect Dis201765696797528541502
   PubMed Web of Science ®Google Scholar
• HizalMBruniCRomanoEDecrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?Clin Rheumatol201534479579825597616
   PubMed Web of Science ®Google Scholar
• MajewskiKAgierJKozłowskaEBrzezińska-BłaszczykESerum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseasesJ Biol Regul Homeost Agents201731373173628956425
   PubMed Web of Science ®Google Scholar
• EdwardsMRBartlettNWClarkeDBirrellMBelvisiMJohnstonSLTargeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary diseasePharmacol Ther2009121111318950657
   PubMed Web of Science ®Google Scholar
• BarnesPJCellular and molecular mechanisms of chronic obstructive pulmonary diseaseClin Chest Med2014351718624507838
   PubMed Web of Science ®Google Scholar
• RanuHWildeMMadden B: pulmonary function testsUlster Med J2011802849022347750
   PubMedGoogle Scholar
• SevenoaksMJStockleyRAChronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype?Respir Res2006717016669999
   PubMed Web of Science ®Google Scholar
• MilacićNMilacićBMilojkovićMCorrelation of C-reactive protein and COPD severityActa Clin Croat20165514148
   Web of Science ®Google Scholar
• ShaykhievRCrystalRGInnate immunity and chronic obstructive pulmonary disease: a mini-reviewGerontology201359648148924008598
   PubMed Web of Science ®Google Scholar